Six Molecular Diagnostic Companies To Watch- CIRCULOGENE featured on Labiotech.eu
Labiotech.eu was founded in 2014 by two biotech engineers in response to the lack of…
Editorial by Dr. Paul Walker: Induction treatment in operable non-small cell lung cancer: the immune oncology era unfold
Induction treatment in operable non-small cell lung cancer: the immune oncology era unfolds Paul R.…
Research indicates that positive PD-L1 detected by CIRCULOGENE liquid biopsy can have favorable outcomes for cancer patients
Research indicates that positive PD-L1 detected by CIRCULOGENE liquid biopsy can have favorable outcomes for…
CIRCULOGENE’s liquid biopsy for PD-L1 status features in research presented at the recent AACR annual meeting
CIRCULOGENE’s liquid biopsy for PD-L1 status features in research presented at the recent AACR annual…
CIRCULOGENE’s blood-based, gene panel is central to research presented at last weekend’s Digestive Disease Week 2023
CIRCULOGENE’s blood-based, gene panel is central to research presented at last weekend’s Digestive Disease Week…
CIRCULOGENE Announces Appointment of Bob Gasparini to Board of Directors
BIRMINGHAM, Ala. and Pensacola, Fla. (December 8, 2022) – CIRCULOGENE is an innovative liquid biopsy company transforming precision…
CIRCULOGENE shares results of remarkable rectal cancer study
FOR IMMEDIATE RELEASE CIRCULOGENE shares results of remarkable rectal cancer study Identifying mismatch repair-deficient (MMRd)…
CIRCULOGENE presented plasma PD-L1 data at the American Society for Radiation Oncology (ASTRO) / American Society of Clinical Oncology (ASCO) Multidisciplinary Thoracic Cancers Symposium
FOR IMMEDIATE RELEASE CIRCULOGENE presented plasma PD-L1 data at the American Society for Radiation Oncology (ASTRO)…
CIRCULOGENE Announces Lab Expansion in Florida
FOR IMMEDIATE RELEASE CIRCULOGENE Announces Lab Expansion in Florida Liquid Biopsy Company Laboratory Operations Are…
CIRCULOGENE Announces Issuance of U.S. Patent for Method of Preparing Cell-Free Nucleic Acid Molecules by In Situ Amplification
Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification,…
Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation
Current Trends in Clinical & Medical Sciences Chen Hsiung Yeh* Circulogene Theranostics, Birmingham, USA Received Date: January…
CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury
$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID…